Paul Edick
Chief Executive Officer at XERIS BIOPHARMA HOLDINGS, INC.
Net worth: 8 M $ as of 2024-03-30
Profile
Paul R.
Edick founded GANIC Pharmaceuticals, Inc. in 2008, where he worked as Chief Executive Officer in 2010.
Mr. Edick also currently works at Xeris Biopharma Holdings, Inc., as Chairman & Chief Executive Officer from 2021.
Mr. Edick also formerly worked at Xeris Pharmaceuticals, Inc., as Chairman, President & Chief Executive Officer from 2017 to 2020, MedPointe, Inc., as President & Chief Executive Officer from 2002 to 2008, MedPointe Healthcare, Inc., as Chief Executive Officer from 2006 to 2008, Durata Therapeutics, Inc., as President, Chief Executive Officer & Director from 2012 to 2014, Veloxis Pharmaceuticals A, as Chairman from 2009 to 2011, Milestone Pharmaceuticals, Inc., as Chairman, Life Cycle Pharma A, as Chairman in 2011, Iterum Therapeutics Plc, as Chairman from 2015 to 2019, NewLink Genetics Corp., as Independent Director from 2011 to 2018, Informed Medical Communications, Inc., as Director from 2006 to 2011, Circassia Ltd., as Non-Executive Director in 2013, Neos Therapeutics, Inc., as Independent Director from 2015 to 2018, Sucampo Pharmaceuticals LLC, as Independent Director, PDL BioPharma, Inc., as Independent Director from 2015 to 2018, Amerita, Inc., as Director, Niox Group Plc, as Independent Non-Executive Director from 2013 to 2016, Baxter Healthcare Corp., as Principal from 1978 to 1990, Procter & Gamble Co., as Sales Representative from 1977 to 1978, Vicuron Pharmaceuticals LLC, as President, G.D.
Searle & Co., Inc., as President-Asia Pacific, Canada & Latin America in 2002, Pharmacia Corp., as VP, President-Asia Pacific & Latin America, MedPointe Capital Partners LLC, as President, 3G Advisors LLC, as Founding Partner, and Searle Pharmaceuticals Pvt Ltd., as President-Asia Pacific, Canada & Latin America.
Mr. Edick received his undergraduate degree from Hamilton College (New York).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-01-30 | 3,821,494 ( 2.72% ) | 8 M $ | 2024-03-30 |
Paul Edick active positions
| Companies | Position | Start |
|---|---|---|
| XERIS BIOPHARMA HOLDINGS, INC. | Chief Executive Officer | 2021-10-04 |
Former positions of Paul Edick
| Companies | Position | End |
|---|---|---|
| ITERUM THERAPEUTICS PLC | Chairman | 2019-06-12 |
| PDL BIOPHARMA, INC. | Director/Board Member | 2018-12-30 |
| LUMOS PHARMA, INC. | Director/Board Member | 2018-04-29 |
| NEOS THERAPEUTICS, INC. | Director/Board Member | 2018-04-26 |
| NIOX GROUP PLC | Director/Board Member | 2016-05-16 |
Training of Paul Edick
| Hamilton College (New York) | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| PROCTER & GAMBLE COMPANY | Consumer Non-Durables |
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| NIOX GROUP PLC | Health Services |
| ITERUM THERAPEUTICS PLC | Health Technology |
| Private companies | 22 |
|---|---|
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Health Technology |
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA. | Health Technology |
Informed Medical Communications, Inc.
 Informed Medical Communications, Inc. Miscellaneous Commercial ServicesCommercial Services Informed Medical Communications, Inc. provides medical forums, training services, and integrated medical communications. It is an interactive medical marketing group of companies providing services to the biopharmaceutical industry. The firm offers a communications training service for elite skill development for sales organizations and speaker bureaus. The company was founded in 2005 and is headquartered in Edison, NJ. | Commercial Services |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Health Technology |
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
Circassia Ltd.
 Circassia Ltd. Pharmaceuticals: OtherHealth Technology Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom. | Health Technology |
MedPointe, Inc.
 MedPointe, Inc. Pharmaceuticals: MajorHealth Technology MedPointe, Inc. develops, markets, and sells therapeutics. The company's products include respiratory, allergy, central nervous system, cough/cold, and pediatric products. The company was founded by James S. Burns and Anthony H. Wild in 2001 and is headquartered in Somerset, NJ. | Health Technology |
G.D. Searle & Co., Inc.
 G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Process Industries |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
MedPointe Capital Partners LLC
 MedPointe Capital Partners LLC Investment ManagersFinance Founded in 2001 by Dr. Anthony Wild, James S. Burns and John T.W. Hawkins, MedPointe Capital Partners LLC is a private equity firm located in Somerset, New Jersey. The firm is known for having led a leveraged buyout of Carter-Wallace to form MedPointe Pharmaceuticals, Inc. | Finance |
Neos Therapeutics, Inc.
 Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX. | Health Technology |
Sucampo Pharmaceuticals, Inc.
 Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
Amerita, Inc.
 Amerita, Inc. Drugstore ChainsRetail Trade Amerita, Inc. provides complex pharmaceutical products and clinical services to patients outside of the hospital. Its services include infusion services, injectable medications, enteral therapy and parenteral therapy, hospice medications and Synagis. The company was founded in 2006 by Jim Glynn and is headquartered in Irvine, CA. | Retail Trade |
MedPointe Healthcare, Inc.
 MedPointe Healthcare, Inc. Pharmaceuticals: MajorHealth Technology MedPointe Healthcare, Inc. operated as a drug manufacturing company. The company was headquartered in Somerset, NJ. | Health Technology |
GANIC Pharmaceuticals, Inc.
 GANIC Pharmaceuticals, Inc. Drugstore ChainsRetail Trade GANIC Pharmaceuticals develops and markets pharmaceutical products. The firm is focused on building fully-integrated pharmaceuticals enterprise focused on certain specialty areas. The company was founded in 2008 and is headquartered in Bridgewater, NJ. | Retail Trade |
| Life Cycle Pharma A/S | |
| 3G Advisors LLC | |
Searle Pharmaceuticals Pvt Ltd.
 Searle Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Searle Pharmaceuticals Pvt Ltd. is a Pakistani company that manufactures pharmaceuticals. The private company is based in Bahawalpur, Pakistan. The CEO of the company is Zubair Razzak Palwala. | Health Technology |
| Xeris Biopharma Holdings, Inc. | |
Durata Therapeutics, Inc.
 Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Durata Therapeutics, Inc. develops and commercializes novel therapeutics for infectious diseases and acute illnesses. The company was founded on November 4, 2009 and is headquartered in Chicago, IL. | Health Technology |
- Stock Market
- Insiders
- Paul Edick
